What is the Global Registry of Acute Coronary Events (GRACE) scoring system for coronary occlusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The GRACE scoring system is a risk assessment tool used to predict mortality in patients with acute coronary syndromes, evaluating eight key variables and providing a total score that helps clinicians make evidence-based decisions regarding treatment intensity and urgency. The GRACE score is calculated based on age, heart rate, systolic blood pressure, serum creatinine level, Killip class, cardiac arrest at admission, ST-segment deviation on ECG, and elevated cardiac biomarkers, with higher scores indicating greater risk of in-hospital and 6-month mortality 1. The total score ranges from 0 to over 300, with scores above 140 generally indicating high risk requiring more aggressive intervention, as supported by the 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation 1.

Key Components of the GRACE Scoring System

  • Age
  • Heart rate
  • Systolic blood pressure
  • Serum creatinine level
  • Killip class
  • Cardiac arrest at admission
  • ST-segment deviation on ECG
  • Elevated cardiac biomarkers

Clinical Application of the GRACE Scoring System

The GRACE score is valuable because it incorporates both clinical presentation and laboratory findings to provide an objective assessment of patient risk, allowing for appropriate triage and management strategies in acute coronary syndrome cases 1. The score can be used to identify patients who might benefit from aggressive therapy, including early myocardial revascularization.

Interpretation of GRACE Scores

Higher GRACE scores indicate a greater risk of mortality, with scores above 140 generally indicating high risk requiring more aggressive intervention 1. The GRACE clinical application tool can be downloaded to a handheld PDA to be used at the bedside and is available at www.outcomes-umassmed.org/grace 1.

From the Research

Definition of the Grace Scoring System

The Global Registry of Acute Coronary Events (GRACE) scoring system is a risk assessment tool used to predict mortality and major adverse cardiac events in patients with acute coronary syndrome (ACS) 2, 3, 4, 5.

Components of the GRACE Scoring System

The GRACE score is calculated based on several factors, including:

  • Age
  • History of ischemic heart disease
  • Heart failure
  • Increased heart rate on admission
  • Serum creatinine level
  • Evidence of myonecrosis
  • Not receiving in-hospital percutaneous coronary intervention 5

Predictive Value of the GRACE Scoring System

The GRACE scoring system has been shown to accurately predict long-term mortality post-ACS, with a C-index of 0.81 at 6 months, 1 year, 2 years, 3 years, and 0.80 at 4 years 5. The modified GRACE scoring system, which includes B-type natriuretic peptide precursor (BNP), has been found to have a higher predictive value than the traditional GRACE scoring system, with an Area Under Curve (AUC) of 0.809 compared to 0.786 3.

Comparison with Other Risk Scores

The GRACE scoring system has been compared to other risk scores, such as the CRUSADE score, and has been found to have superior predictive value for in-hospital mortality, with an AUC of 0.91 compared to 0.83 4. However, the performance of the GRACE score for predicting major bleeding has been found to be poor, with an AUC of 0.71 4.

Clinical Application

The GRACE scoring system can be used to risk-stratify patients with ACS and guide treatment decisions, such as the use of invasive coronary angiography and percutaneous or surgical revascularization 6.

Related Questions

What score is used to calculate ischemic risk post Acute Coronary Syndrome (ACS)?
What does the GRACE (Global Registry of Acute Coronary Events) score measure?
What is the role of GRACE (Global Registry of Acute Coronary Events) scoring in managing patients with acute coronary syndrome?
What is the best course of action for a patient with a history of myocardial infarction, presenting with intermittent chest and leg pain, nausea, and impaired renal function, while on clopidogrel, dapagliflozin, sitagliptin, atorvastatin, gliglazide, amlodipine, and losartan?
What is the treatment for a 65-year-old man with difficulty breathing and a respiratory rate (RR) showing a respiratory sinus arrhythmia (RSA) pattern in leads V2 and V3 on an electrocardiogram (ECG)?
What is the comparison between Beta (beta) blockers and Calcium Channel (CCB) blockers?
What is the management approach for a 43-year-old patient with paraplegia, deep vein thrombosis (DVT) and pulmonary embolism (PE) on Eliquis (apixaban), with an ostomy bag, end-stage renal disease (ESRD) on dialysis, presenting with recurrent asymptomatic tachycardia and severe anemia?
What is the rehabilitation protocol for conservative management of a distal radius (DR) fracture?
What is the diagnosis for a patient with a biopsy showing proliferative endometrium (inner lining of the uterus) with foci of tubal metaplasia, and no evidence of endometrial hyperplasia, atypia, or malignancy?
What is the maximum duration of mometasone (mometasone) cream use?
What are the causes of pseudobulbar palsy (Progressive Bulbar Palsy)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.